Antisense oligonucleotide splicing modulation as a novel Cystic Fibrosis therapeutic approach for the W1282X nonsense mutation-Reference-Cited by-同舟云学术

Antisense oligonucleotide splicing modulation as a novel Cystic Fibrosis therapeutic approach for the W1282X nonsense mutation

Published:2021-12 Issue: Volume: Page:
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Oren Yifat S.,Avizur-Barchad Ofra,Ozeri-Galai Efrat,Elgrabli Renana,Schirelman Meital R.,Blinder Tehilla,Stampfer Chava D.,Ordan Merav,Laselva Onofrio,Cohen-Cymberknoh Malena,Kerem Eitan,Bear Christine E,Kerem Batsheva

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Reference22 articles.

1. CFTR2 n.d.

2. Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung disease;Shteinberg;Eur Respir Rev,2020

3. An update on new and emerging therapies for cystic fibrosis;Hudock;Expert Opin Emerg Drugs,2017

4. From the endoplasmic reticulum to the plasma membrane: mechanisms of CFTR folding and trafficking;Farinha;Cell Mol Life Sci,2017

5. The DeltaF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR;Du;Nat Struct Mol Biol,2005

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ABC transporters involved in respiratory and cholestatic diseases: From rare to very rare monogenic diseases;Biochemical Pharmacology;2024-11

2. Enhancing peptide and PMO delivery to mouse airway epithelia by chemical conjugation with the amphiphilic peptide S10;Molecular Therapy - Nucleic Acids;2024-09

3. Systematic deletion of symmetricalCFTRexons reveals new therapeutic targets for exon skipping antisense oligonucleotides;2024-08-29

4. The expanded French compassionate programme for elexacaftor–tezacaftor–ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study;The Lancet Respiratory Medicine;2024-08

5. A new era of targeting cystic fibrosis with non-viral delivery of genomic medicines;Advanced Drug Delivery Reviews;2024-06